Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Editors' Blog
    • Email Alerts
  • Info For
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • About
    • The JABFM
    • Editorial Board
  • Classifieds
  • More
    • Email Alerts
    • Feedback
    • ABFM News
    • Folders
    • Help
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Editors' Blog
    • Email Alerts
  • Info For
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • About
    • The JABFM
    • Editorial Board
  • Classifieds
  • More
    • Email Alerts
    • Feedback
    • ABFM News
    • Folders
    • Help
  • JABFM On Twitter
  • JABFM On YouTube
  • JABFM On Facebook
Research ArticleOriginal Research

The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System

Thomas F. Northrup, Kelley Carroll, Robert Suchting, Yolanda R. Villarreal, Mohammad Zare and Angela L. Stotts
The Journal of the American Board of Family Medicine May 2019, 32 (3) 362-374; DOI: https://doi.org/10.3122/jabfm.2019.03.180356
Thomas F. Northrup
the Department of Family and Community Medicine, University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School, Houston, TX (TFN, KC, YRV, MZ, ALS); Ambulatory Care Services, Grady Health System, Atlanta, GA (KC); Department of Psychiatry and Behavioral Sciences, UTHealth McGovern Medical School, Houston, TX (RS, ALS).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelley Carroll
the Department of Family and Community Medicine, University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School, Houston, TX (TFN, KC, YRV, MZ, ALS); Ambulatory Care Services, Grady Health System, Atlanta, GA (KC); Department of Psychiatry and Behavioral Sciences, UTHealth McGovern Medical School, Houston, TX (RS, ALS).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Suchting
the Department of Family and Community Medicine, University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School, Houston, TX (TFN, KC, YRV, MZ, ALS); Ambulatory Care Services, Grady Health System, Atlanta, GA (KC); Department of Psychiatry and Behavioral Sciences, UTHealth McGovern Medical School, Houston, TX (RS, ALS).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yolanda R. Villarreal
the Department of Family and Community Medicine, University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School, Houston, TX (TFN, KC, YRV, MZ, ALS); Ambulatory Care Services, Grady Health System, Atlanta, GA (KC); Department of Psychiatry and Behavioral Sciences, UTHealth McGovern Medical School, Houston, TX (RS, ALS).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Zare
the Department of Family and Community Medicine, University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School, Houston, TX (TFN, KC, YRV, MZ, ALS); Ambulatory Care Services, Grady Health System, Atlanta, GA (KC); Department of Psychiatry and Behavioral Sciences, UTHealth McGovern Medical School, Houston, TX (RS, ALS).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela L. Stotts
the Department of Family and Community Medicine, University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School, Houston, TX (TFN, KC, YRV, MZ, ALS); Ambulatory Care Services, Grady Health System, Atlanta, GA (KC); Department of Psychiatry and Behavioral Sciences, UTHealth McGovern Medical School, Houston, TX (RS, ALS).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Hydrocodone-combination analgesics were changed from Schedule III to Schedule II to discourage the prescribing of these analgesics. Our primary aim was to explore the effect of hydrocodone rescheduling on opioid prescribing within an urban safety-net health care system.

Methods and Design: Data were extracted from electronic records of ambulatory patients (N = 82,432 patients) prescribed hydrocodone-combination, codeine-combination, or tramadol opioid analgesics (N = 200,675 prescriptions) between October 6, 2013 and October 6, 2015. Data analyses modeled predicted probabilities of hydrocodone-combination prescriptions (HCPs). Chronic opioid therapy (COT) for chronic pain (ie, ≥3 opioid prescriptions/12 months) and morphine milligram equivalency (MME) levels were also examined.

Results: The probability of providers writing HCPs decreased significantly from pre- to postrescheduling (0.525 vs 0.158, respectively, P < .0001). However, this coincided with large probability increases in codeine-combination (0.064 vs 0.269) and tramadol prescriptions (0.412 vs 0.573). The probability of HCPs varied across physician specialty (P < .0001), patient diagnoses (P < .0001), COT versus non-COT patients (P < .0001), and patient characteristics (sex, race/ethnicity, and age; P < .05). COT patients received significantly more opioid prescriptions in the postrescheduling period (M = 4.81 vs M = 4.27; P < .0001). Patients on <20 MME/day increased slightly from pre- to postrescheduling (P < .0001).

Discussion: Significant declines in HCPs occurred after rescheduling; however, one third of patients prescribed opioids remained on doses ≥20 MME/day. Codeine- and tramadol-prescription probabilities increased significantly and providers may have an increased perception of safety about these medications. Physicians and health care systems must reduce their overreliance on opioids in treating pain, especially chronic pain, as all opioids incur some level of risk.

  • Codeine-Combination
  • Hydrocodone
  • Hydrocodone-Combination
  • MME
  • Opioid Prescription
  • Rescheduling
  • Tramadol
View Full Text
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 32 (3)
The Journal of the American Board of Family Medicine
Vol. 32, Issue 3
May-June 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 10 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System
Thomas F. Northrup, Kelley Carroll, Robert Suchting, Yolanda R. Villarreal, Mohammad Zare, Angela L. Stotts
The Journal of the American Board of Family Medicine May 2019, 32 (3) 362-374; DOI: 10.3122/jabfm.2019.03.180356

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System
Thomas F. Northrup, Kelley Carroll, Robert Suchting, Yolanda R. Villarreal, Mohammad Zare, Angela L. Stotts
The Journal of the American Board of Family Medicine May 2019, 32 (3) 362-374; DOI: 10.3122/jabfm.2019.03.180356
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Statistical Analyses
    • Results
    • Discussion
    • Conclusion
    • Notes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Family Medicine: Data Driven Practice with Emphasis on Underserved Patients
  • Google Scholar

More in this TOC Section

  • Primary Care Relevant Risk Factors for Adverse Outcomes in Patients With COVID-19 Infection: A Systematic Review
  • Key Factors Promoting Rapid Implementation of Virtual Screening Modalities for the COVID-19 Pandemic Response
  • On the Front (Phone) Lines: Results of a COVID-19 Hotline
Show more ORIGINAL RESEARCH

Similar Articles

Keywords

  • Codeine-Combination
  • Hydrocodone
  • Hydrocodone-Combination
  • MME
  • Opioid Prescription
  • Rescheduling
  • Tramadol

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us

© 2021 American Board of Family Medicine

Powered by HighWire